. Although ST92 showed moderate resistance to carbapenems, most ST75 and ST138 isolates were resistant to carbapenems. All ST75 and ST138 isolates, but only one ST92 isolate, contained the bla OXA-23-like gene. Increased carbapenem resistance in Acinetobacter species and A. baumannii isolates might be due to the expansion of specific carbapenem-resistant clones.
INTRODUCTION
Acinetobacter species have garnered significant attention as emerging opportunistic nosocomial pathogens in intensive care units (Peleg et al., 2008) . Epidemic spread and outbreaks of multidrug-resistant or carbapenem-resistant Acinetobacter baumannii (CRAB) infections have been described worldwide (Perez et al., 2007) . Various studies have shown that many strains from outbreaks in Europe and beyond belong to three major clones, the European (EU) clones I-III. These clones can be identified by amplified fragment length polymorphism analysis, a high-resolution genomic fingerprinting method by which isolates are compared to reference strains of these clones (Dijkshoorn et al., 1996; van Dessel et al., 2004) . Recently, the existence of these clones was confirmed by multilocus sequence typing (MLST) (Diancourt et al., 2010) .
Korea is one of the countries in which Acinetobacter species isolates have high rates of resistance to carbapenems (Lee et al., 2006) . While about 10 % of Korean Acinetobacter species isolates were resistant to carbapenems in one study (Ko et al., 2007) , another study reported that more than 30 % of Acinetobacter species isolates were imipenemresistant (Lee et al., 2007) . It has been suggested that a limited number of clones may contribute to the high carbapenem resistance rate (up to 32.5 %) in A. baumannii isolates from Korea (Lee et al., 2007; Park et al., 2009a Park et al., , 2010 . Due to the high rates of resistance to carbapenems, use of colistin as a last resort is increasing (Nation & Li, 2009) . Although colistin or polymyxin B resistance rates amongst Acinetobacter species isolates are very low worldwide so far (Gales et al., 2006) , high rates of resistance to colistin and polymyxin B in Acinetobacter species isolates have been reported in Korea (Ko et al., 2007; Park et al., 2009b) . Colistin resistance has been frequently found in species other than A. baumannii, presumably as the result of independent emergence (Park et al., 2009b) . However, change of antimicrobial resistance over time in relation to the change of major clones of A. baumannii has not been investigated in Korea.
In the present study, we collected Acinetobacter species isolates causing bloodstream infections from a single hospital in Korea over a 7-year period from 2003 to 2010. Antimicrobial susceptibility testing and MLST were performed to investigate the longitudinal change of antimicrobial resistance and main clones.
METHODS
Collection of Acinetobacter species isolates and species identification. A total of 287 Acinetobacter species isolates from patients with bloodstream infections were collected from one tertiarycare hospital in Korea from August 2003 to February 2010 : 12 in 2003 , 29 in 2004 , 52 in 2005 , 34 in 2006 , 44 in 2007 , 40 in 2008 , 69 in 2009 and 7 in 2010 . Acinetobacter species isolates were differentiated into two groups according to the time period of collection: 2003-2007 (171 isolates) and 2008-2010 (116 isolates) . Subdivision into two periods was made because an increase of carbapenem resistance has been observed since 2008. Only the first isolate from each patient was included in this study. Initially, isolates that were identified as Acinetobacter species were included in the VITEK 2 system. Species identification was performed using partial rpoB gene sequences (Ko et al., 2007; La Scola et al., 2006) . Acinetobacter genomic species 'close to 13TU' (AGS-'close to 13TU'), which has been denoted as A. baumannii-like (Aba-like) species or Aba-B group (Ko et al., 2007; Park et al., 2009b) , was also identified. Although AGS-'close to 13TU' could be classified into A. baumannii due to the presence of a bla OXA-51-like gene, it formed a distinct cluster from A. baumannii by MLST.
In vitro antimicrobial susceptibility testing. In vitro antimicrobial susceptibility testing was performed with all Acinetobacter species isolates by measuring the MIC using the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 2009) . Fifteen antimicrobial agents were tested: imipenem, meropenem, polymyxin B, colistin, tetracycline, ciprofloxacin, rifampicin, amikacin, cefepime, ceftriaxone, cefaperazonesulbactam, ceftazidime, piperacillin-tazobactam, ampicillin-sulbactam and tigecycline. CSLI susceptibility interpretive criteria were used (CLSI, 2009) (Paterson & Doi, 2007) .
MLST and antimicrobial resistance genes. MLST was performed for 127 A. baumannii isolates as previously described (Bartual et al., 2005) with some modifications (Park et al., 2009a) . All MLST data including newly identified alleles and sequence types (STs) were submitted to the A. baumannii MLST database (http://pubmlst.org/ abaumannii). Clonal complexes were determined using the eBURST program (Feil et al., 2004) . For 65 CRAB isolates and eight carbapenem-resistant Acinetobacter pittii isolates, genes encoding oxacillinase (OXA) carbepenemases, such as bla OXA23-like , bla OXA24-like , bla OXA51-like and bla OXA58-like , were identified as previously described (Woodford et al., 2006) . In addition, bla PER , bla IMP and bla VIM were also tested by PCR as previously described (Hujer et al., 2006) .
Statistical analysis. Fisher's exact t-test was used to determine the significant differences in resistance using SPSS for Windows (version 11.5).
RESULTS

Species distribution of Acinetobacter isolates
The most prevalent species was A. baumannii, but it represented under half of the total Acinetobacter species isolates (44.2 %) ( Table 1 ). The A. baumannii isolation rate increased from 40.4 % in 2003-2007 to 50.0 % in 2008-2010 , which was not significant (P50.106). The second most prevalent species was A. nosocomialis (formerly AGS 13TU; n598 isolates, 34.1 %) (Nemec et al., 2011) . The high prevalence of A. nosocomialis was notable in this study. AGS-'close to 13TU' species was identified in 28 isolates (9.8 %). It was the second most frequently isolated species in 2005 (21.2 %), but was less prevalent (4.3-14.3 %) in the other years (Table 1) . Fifteen isolates (5.2 %) belonged to A. pittii (formerly AGS 3) (Nemec et al., 2011) . Other Acinetobacter species such as A. calcoaceticus, Acinetobacter junii, Acinetobacter parvus, Acinetobacter ursingii, AGS-10 and AGS-16 were isolated sporadically. Species distribution was not different significantly between the two time periods.
Antimicrobial resistance amongst A. baumannii isolates Antimicrobial resistance rates of A. baumannii changed significantly between two periods: 2003-2007 and 2008-2010 . The most notable change was in carbapenem resistance ( Fig. 1 ). Imipenem resistance rates in A. baumannii isolates increased from 15.9 % in 2003-2007 to 77.6 % in 2008-2010 (P,0.001 ). Meropenem resistance rates in A. baumannii isolates increased from 29.0 % in 2003-2007 to 77.6 % in 2008-2010 (P,0.001) . Very low resistance rates of polymyxin B and colistin were identified amongst A. baumannii isolates. Only five (3.9 %) and three (2.4 %) A. baumannii isolates were resistant to polymycin B and colistin, respectively (Fig. 1) . Notably, however, these polymyxin B-or colistin-resistant A. baumannii isolates were obtained only in 2009 and 2010. Amongst A. baumannii isolates, resistance rates were very high, ranging from 57.5 % for amikacin to 81.9 % for ceftriaxone (Fig. 1 ). However, a significant increase in antimicrobial resistance rate amongst A. baumannii isolates was found only for ampicillin-sulbactam (P50.049). On the other hand, the amikacin resistance rate amongst A. baumannii isolates decreased significantly (P50.008). Increase of the resistance rates for several antimicrobial agents, except the carbapenems, was noticeable in A. nosocomialis: 1.7 % to 25.6 % for tetracycline, 1.7 % to 30.8 % for ciprofloxacin, 15.5 % to 43.6 % for cefepime, 8.6 % to 20.5 % for piperacillin-tazobactam and 1.7 % to 17.9 % for ampicillin-sulbactam.
In this study, seven tigecycline-resistant Acinetobacter species isolates were identified (MIC ¢8 mg l
21
). Of these, six isolates belonged to A. baumannii. In particular, four tigecycline-resistant A. baumannii isolates were identified in 2009. However, these four tigecycline-resistant A. baumannii isolates belonged to three different clones, ST138 (two isolates), ST69 (one isolate) and ST92 (one isolate). Two tigecycline-resistant A. baumannii isolates in both 2004 and 2005 belonged to ST92. Although tigecycline-resistant Acinetobacter species isolates including A. baumannii were rare, tigecycline-nonsusceptible isolates (MIC ¢4 mg l 21 ) were not. Sixty-nine Acinetobacter species isolates (24.0 %) were nonsusceptible to tigecycline. Moreover, 52 A. baumannii isolates (40.9 %) were nonsusceptible to tigecycline. However, tigecycline-nonsusceptibility rates amongst A. baumannii isolates decreased from 46.4 % in 2003-2007 to 34.5 % in 2008-2010 (data not shown).
Comparison of antimicrobial resistance amongst Acinetobacter species Table 2 summarizes the antimicrobial resistance of A. baumannii, A. nosocomialis, A. pittii, AGS-'close to 13TU' and A. calcoaceticus. A. baumannii and A. pittii both showed a high carbapenem resistance rate of 53.3 %. A few isolates of A. nosocomialis and AGS-'close to 13TU' were resistant to carbapenems. Isolates resistant to polymyxins were most frequently in AGS-'close to 13TU', followed by A. nosocomialis. Only a few A. baumannii isolates were resistant to polymyxins. While no tigecycline-nonsusceptible isolates were found in A. pittii, 40.9 % of the A. baumannii isolates were nonsusceptible to tigecycline despite the low rate of tigecycline resistance. Resistance rates to the other antimicrobial agents differed amongst the four Acinetobacter species. A. nosocomialis showed low resistance rates for most antimicrobial agents except rifampicin, and only 10.2 % of A. nosocomialis isolates were MDR. A. pittii showed high resistance rates to cephalosporins such as cefepime, ceftriaxone and ceftazidime, but a low resistance rate to rifampin. Similar to A. nosocomialis, AGS-'close to 13TU' A. calcoaceticus-baumannii complex in Korea presented low resistance rates to most of the tested antimicrobial agents.
MDR isolates
In this study, 99 A. baumannii isolates (78.0 %) were identified as MDR (Fig. 1) . Amongst the A. baumannii isolates, MDR rates also increased from 73.9 % in 2003-2007 to 82.3 % in 2008-2010 (P50.231) (Fig. 1) . Only 10.2 % and 10.7 % of A. nosocomialis and AGS-'close to 13TU' were MDR isolates, respectively. Antimicrobial resistance to tigecycline and polymyxins amongst the MDR isolates was analysed (Fig. 2) . Resistance to tigecycline and polymyxins was also very low amongst 99 MDR A. baumannii isolates. However, about half of the MDR A. baumannii isolates were tigecycline nonsusceptible.
Genotypes of A. baumannii isolates
Most of the A. baumannii isolates belonged to the same clonal complex consisting of ST92 and its single-locus and double-locus variants (Fig. 3) (Feil et al., 2004) . The most prevalent clone amongst the A. baumannii isolates was ST92 (33.9 %), followed by ST72 (18.1 %), ST138 (12.6 %) and ST69 (9.4 %) (Fig. 4) Antimicrobial resistance for several agents differed significantly amongst the main genotypes of A. baumannii isolates. While imipenem and meropenem resistance rates were low in ST92 isolates, they were very high in ST69, ST75 and ST138 isolates (Table 3 ). Most isolates of the two clones prevalent in 2008-2010, ST75 and ST138, were resistant to carbapenems. In contrast to the other three clones, only 20.9 % and 27.9 % of ST92 isolates were resistant to imipenem and meropenem, respectively. In addition to carbapenems, most polymyxin B-or colistinresistant A. baumannii isolates were found in clones ST75 and ST138 that predominated from 2008 to 2010. However, ST138 showed a lower antimicrobial resistance rate to tetracycline, and only 17.4 % of ST75 isolates were resistant to rifampicin. In addition, the amikacin resistance rate of ST75 and ST138 was lower than that of ST92 and ST69. In particular, all ST69 isolates were intermediate or resistant to tigecycline. Most isolates of the four main A. baumannii clones were MDR.
Antimicrobial resistance genes
All of the CRAB isolates included in this study possessed the bla OXA-51-like gene, which is intrinsic to A. baumannii. bla OXA-23-like genes were found in 38 of 65 CRAB isolates (58.5 %) ( 
DISCUSSION
One of the interesting results in this study was the high prevalence of A. nosocomialis amongst the Acinetobacter species isolates causing bacteraemia. A. nosocomialis has been grouped together with A. baumannii, A. calcoaceticus and A. pittii in the A. calcoaceticus-baumannii complex, as it is difficult to differentiate phenotypically (Dijkshoorn et al., 2007; Wisplinghoff et al., 2008) . In addition to these four Acinetobacter species, AGS-'close to 13TU' has also been included in the A. calcoaceticus-baumannii complex (Ko et al., 2007; Park et al., 2009b) . Although it is known that A. baumannii, A. nosocomialis and A. pittii are clinically relevant and are responsible for most nosocomial infections, precise identification amongst them is not performed routinely in most laboratories worldwide (Dijkshoorn et al., 2007) . Although A. pittii or A. nosocomialis is the most prevalent amongst clinical isolates from Sweden, Ireland or 
A. calcoaceticus-baumannii complex in Korea
Norway (Wisplinghoff et al., 2008; Boo et al., 2009; Karah et al., 2011) , it is assumed that A. baumannii is the most prevalent worldwide including in Korea (Dijkshoorn et al., 2007; Ko et al., 2007; Lee et al., 2007; Donnarumma et al., 2010; Turton et al., 2010) . However, understanding of the precise distribution of species of the A. calcoaceticusbaumannii complex is required because Acinetobacter species display quite different antimicrobial resistance profiles (Ko et al., 2007; Lee et al., 2007) . In this study, carbapenem resistance (44.1 % for imipenem and 51.2 % for meropenem) was more common in A. baumannii and A. pittii than in the other species. High resistance in A. pittii is particularly worrying because A. pittii also circulates in the community (Espinal et al., 2011) . The main carbapenem resistance mechanism in A. pittii was a metallo-b-lactamase such as IMP-1. In addition, while 78.0 % of A. baumannii isolates were MDR, only 10.2 % and 10.7 % of A. nosocomialis and AGS-'close to 13TU' isolates were MDR, respectively. However, most AGS-'close to 13TU' isolates were resistant to polymyxins (50.0 % to polymyxin B and (Park et al., 2009a (Park et al., , 2010 , has long been presumed to be the most prevalent A. baumannii clone in Korea. It has also been reported in Germany, Hong Kong and Taiwan in Bartual's MLST system (http://pubmlst.org/abaumannii/) (Bartual et al., 2005; Hamouda et al., 2010) . A prior study performed in a different hospital in Korea from 2006 to 2007 suggested that ST92 (previously designated ST22) was responsible for the high rate of carbapenem resistance in Acinetobacter species isolates in the institution (Park et al., 2010 (Fig. 3) , it is assumed that ST92 underwent mutations accompanied by acquisition of carbapenem resistance. In addition, most polymyxin-resistant A. baumannii isolates belong to ST75. All of the ST75 and ST138 isolates possess OXA-23-like enzymes as well as OXA-51-like enzymes intrinsic to A. baumannii (Dijkshoorn et al., 2007) . Although it has been reported that ST92 (formerly ST22) is the most frequent clone in A. baumannii isolates producing OXA-23-like enzyme worldwide (Mugnier et al., 2010) , only one isolate of ST92 was positive for it in the current study. This result is compatible with the recent finding that the recent and rapid increase of imipenemnonsusceptible A. baumannii isolates in Korea is mainly due to clonal spread of OXA-23-producing isolates (Kim et al., 2010) . It is reasonable to postulate that the increased use of carbapenems and polymyxins to treat infections by Gramnegative pathogens has acted as a selection pressure for carbapenem-or polymyxin-resistant resistant clones such as ST75 and ST138. The selection of the ST75 and ST138 A. baumannii clones might have been favoured by the acquisition of the bla OXA23-like gene causing high carbapenem resistances (Giannouli et al., 2010) .
Both the ST75 and ST138 clones are single-locus variants of ST92, differing only in the gpi locus. ST75 and ST92 differ at two nucleotide sites, and ST138 differs from ST92 at seven sites. A change at the gpi locus is thought to occur by recombination and not by point mutation (Feil et al., 2000 (Feil et al., , 2003 . The gpi locus is prone to recombination (Park et al., 2009b; Hamouda et al., 2010) . Thus, a region flanking the gpi gene may be accompanied by antimicrobial resistance determinants or a determinant that is advantageous for survival of an A. baumannii isolate, which may arise due to a hitchhiking mechanism as in the ddl gene and pbp2b gene, endowing penicillin resistance in Streptococcus pneumoniae (Enright & Spratt, 1999) . In addition, a low diversity of several clones was observed in the present study. It has been suggested that A. baumannii has recently experienced a bottleneck in a study using another MLST system (Diancourt et al., 2010) . A narrow ecological niche of A. baumannii or restricted diversity of only clinical isolates might result in such a bottleneck. Despite such similar genetic backgrounds of A. baumannii isolates in Korea, different features of the main clones are also of concern. In addition, our study may indicate the geographically large differences in A. calcoaceticus-baumannii complex species and antimicrobial susceptibilities. For example, A. pittii as well as A. baumannii was prevalent in a study performed in the Netherlands (van den Broek et al., 2009) . In Norway, A. nosocomialis was the most prevalent amongst Acinetobacter species blood culture isolates (Karah et al., 2011) . In addition, complete susceptibility to imipenem of A. pittii isolates was reported in that study, which is contrast to the result of our study.
In this study, we investigated antimicrobial resistance and genotypes of A. calcoaceticus-baumannii complex isolates including A. baumannii isolated from patients with 
